Literature DB >> 7518062

Further evidence that pyrroloquinoline quinone interacts with the N-methyl-D-aspartate receptor redox site in rat cortical neurons in vitro.

E Aizenman1, F E Jensen, P M Gallop, P A Rosenberg, L H Tang.   

Abstract

In this study, we show that the essential nutrient pyrroloquinoline quinone (PQQ; 50 microM) regulates N-methyl-D-aspartate (NMDA; 10 microM) receptor activity primarily by reversing the increase in the frequency of openings of the receptor-associated ion channel after chemical reduction with dithiothreitol (DTT; 1 mM). Similar to other redox-active agents, PQQ (50-200 microM) had no effect on the single-channel conductance or arithmetic mean open time of NMDA-activated events. In other experiments, we observed that inhibitory effects of PQQ (50 microM) on NMDA (30 microM)-induced whole-cell responses could be abolished by prior N-ethylmaleimide (500 microM) alkylation of the putative thiol residues that likely comprise the redox site of the receptor. These results demonstrate that PQQ modulates the NMDA receptor by directly oxidizing its redox modulatory site.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7518062     DOI: 10.1016/0304-3940(94)90447-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Protective Effect of Pyrroloquinoline Quinone (PQQ) in Rat Model of Intracerebral Hemorrhage.

Authors:  Hongjian Lu; Jiabing Shen; Xinjian Song; Jianbin Ge; Rixin Cai; Aihua Dai; Zhongli Jiang
Journal:  Cell Mol Neurobiol       Date:  2015-03-29       Impact factor: 5.046

2.  Lack of interaction between nitric oxide and the redox modulatory site of the NMDA receptor.

Authors:  E Aizenman; W K Potthoff
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

3.  Supplementation of PQQ from pregnancy prevents MK-801-induced schizophrenia-like behaviors in mice.

Authors:  Ying Peng; Dong Xu; Yuedi Ding; Xingqin Zhou
Journal:  Psychopharmacology (Berl)       Date:  2022-03-16       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.